Tilray shared an update regarding the completion of a successful harvest at Tilray Portugal Unipessoal Lda.
Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived medical products. "We have greatly invested in this 250,000 square-feet facility, providing it with additional room to expand. This structure will also function as a hub supporting Tilray’s clinical research and product development efforts across Europe.", the team with the company explains.
"Tilray was one of the first licensed medical cannabis producers to successfully import medical cannabis products into the EU and one of the first licensed medical cannabis producers in North America to obtain Good Manufacturing Practice (GMP) certification in accordance with the European Medicines Agency’s (EMA) standards. Tilray has established sales and distribution arrangements to distribute medical cannabis through major pharmaceutical distribution channels throughout Germany and the European Union.", the company concludes.
For more information: